{
  "url": "https://openlegislation.uk/general-pharmaceutical-council-fitness-to-practise-and-disqualification-etc-rules-order-of-council-2010/schedule/rule-34",
  "json_url": "https://openlegislation.uk/general-pharmaceutical-council-fitness-to-practise-and-disqualification-etc-rules-order-of-council-2010/schedule/rule-34.json",
  "legislation": "uksi/2010/1615",
  "legislation_title": "The General Pharmaceutical Council (Fitness to Practise and Disqualification etc. Rules) Order of Council 2010",
  "legislation_url": "https://openlegislation.uk/general-pharmaceutical-council-fitness-to-practise-and-disqualification-etc-rules-order-of-council-2010",
  "path": "schedule/rule/34",
  "kind": "rule",
  "number": "34",
  "heading": "Procedure at review hearings",
  "text": "(1) Unless the Committee determines otherwise, the order of proceedings at a review hearing is to be in accordance with paragraphs (2) to (9A).\n(2) The Committee must hear and consider any preliminary legal arguments.\n(3) The chair must—\n(a) where the person concerned is present or represented, require the person concerned to confirm their name; or\n(b) otherwise, require the presenter to confirm the person concerned’s name.\n(4) The presenter —\n(a) must inform the Committee of the background to the case, and the sanction previously imposed or undertaking entered into;\n(b) must direct the attention of the Committee to any relevant evidence, including transcripts of previous hearings; and\n(c) may adduce evidence and, subject to paragraph (10), call witnesses in relation to the person concerned’s fitness to practise or, as the case may be, their failure to comply with an undertaking or with any requirement imposed as a condition of registration.\n(5) The person concerned may present their case, adduce evidence and, subject to paragraph (10), call witnesses in support of it.\n(6) The Committee must receive further evidence and hear any further submissions from the parties—\n(a) where the Committee has given a direction under article 54(2)(d) or (e) of the Order, as to what direction to give, if any, under article 54(3) of that Order;\n(b) where the person concerned has given an undertaking, as to whether the person concerned has breached the undertaking;\n(c) where the Committee has given a direction under section 80(1) or (4) of the Act, as to whether that direction should be revoked.\n(7) The Committee must consider and announce its finding on the relevant question in paragraph (6) and give its reasons for that decision.\n(8) The Committee must consider and announce its decision as to—\n(a) the direction, if any, to be given under article 54(3) of the Order; or\n(b) the revocation of the direction under section 80(1) or (4) of the Act,\nand give its reasons for that decision.\n(9) Where the Committee finds that an undertaking has not been complied with, it may—\n(a) in fitness to practise proceedings, determine that the registrant’s fitness to practise is impaired on the basis of that failure to comply and make a determination under article 54(2) of the Order;\n(b) in disqualification proceedings, treat the failure as misconduct and give a direction under section 80(1) or (4) of the Act.\n(9A) In making a decision under paragraph (9), the Committee must have regard to any guidance issued by the Council about sanctions that particular classes of cases before the Committee should attract.\n(10) The chair may refuse to allow a witness to give oral evidence, or to give oral evidence on a particular matter—\n(a) if not satisfied that the witness is in a position to provide relevant testimony; or\n(b) if satisfied that all or part of the evidence that the witness is to provide, or is to provide on that matter, should have been disclosed to the party not calling the witness at an earlier stage in the proceedings.\n(11) Notwithstanding the procedure set out in paragraphs (2) to (9), the Committee may allow the parties to make additional submissions at any time.",
  "extent": "E+W+S",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Words in Sch. rule 34(1) substituted (5.2.2013) by The General Pharmaceutical Council (Amendment of Miscellaneous Provisions) Rules Order of Council 2012 (S.I. 2012/3171), Sch. rules 2, 23(2)"
    },
    {
      "type": "F",
      "label": "F2",
      "text": "Sch. rule 34(9A) inserted (5.2.2013) by The General Pharmaceutical Council (Amendment of Miscellaneous Provisions) Rules Order of Council 2012 (S.I. 2012/3171), Sch. rules 2, 23(3)"
    },
    {
      "type": "I",
      "label": "I1",
      "text": "Sch. rule 34 in force at 27.9.2010, see Sch. rule 1"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2010/1615/schedule/rule/34",
    "retrieved_at": "2026-11-12T03:40:41.353848+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}